Morgan Stanley analyst Kristine Liwag raised the firm’s price target on Rocket Lab (RKLB) to $18 from $6.50 and keeps an Equal Weight rating on the shares. The stock is up about 30% since the company announced an agreement with an initial, unnamed customer for Neutron and the firm is increasing its base case range to $10-$25 on improved Neutron visibility, but adds that it expects the stock to remain volatile ahead of initial launch.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio